Cannanda Launches Free Trial Program for CB2 Oil, Offering Hope to ME/

Cannanda CB2 products, featuring beta-caryophyllene, are already being used in the Remission Biome clinical trial for ME/CFS and long covid

Cannanda CB2 oil is a multi-award-winning beta-caryophyllene product and often included as part of the free trial program for those with ME/CFS, long covid, or fibromyalgia

TORONTO, ON, January 15, 2024 /3DMC Presss/ – Cannanda, the trailblazing innovator behind CB2 oil, proudly announces the launch of a Free Trial program, offering individuals with ME/CFS, long covid, and fibromyalgia a risk-free opportunity to experience the potential benefits of Cannanda CB2 products. This initiative aligns with Cannanda's commitment to prioritizing “patients over profits,” a core value since its inception in 2016.

About CB2 Oil:

Safe, Legal, and Affordable: CB2 oil is a safe, legal, and cost-effective.
Based on Beta-Caryophyllene (BCP): Harnessing the power of beta-caryophyllene (BCP), CB2 oil has garnered popularity among natural health enthusiasts and those battling chronic illnesses. In fact, as the premier and doctor-recommended beta-caryophyllene supplement, Cannanda CB2 products were chosen as part of an experimental clinical trial protocol for ME/CFS and long covid. This trial is organized and executed by Remission Biome, an organization founded by two passionate PhD researchers.
No Adverse Drug Interactions: CB2 oil has no adverse drug interactions when used as recommended—an important note since many with ME/CFS, long covid, and fibromyalgia might already taking a number of medications.
High Success Rate: Boasting a success rate of approximately 60-70%, CB2 oil provides hope to individuals seeking relief from ME/CFS, long covid, and fibromyalgia.

The Science Behind CB2 Oil:

At the heart of CB2 oil's efficacy is BCP's unique ability to directly activate CB2 receptors in the body. This activation triggers a cascade of beneficial effects, including modulation of the immune system and reduction of inflammation. By targeting CB2 receptors, CB2 oil offers a potential avenue for improving chronic conditions such as ME/CFS, long covid, and fibromyalgia.

The Free Trial Program:

Recognizing the financial constraints many face in their healing journey, Cannanda's Free Trial program allows individuals to try CB2 oil at no cost. This initiative is designed for those who have tirelessly explored various products and services in search of relief, offering them an opportunity to experience the potential benefits without financial burden.

Most with ME/CFS, long covid, and fibromyalgia will find varying results from different products (or combination of products). Everyone has their unique physiology and genetics, and root cause of their ME/CFS, long covid, and fibromyalgia; and the trial-and-error process to find the right fit for their body is often an expensive one. Cannanda hopes this Free Trial program will help patients determine whether Cannanda CB2 oils work for them or not without incurring the expense of what is typically a long process of finding the right solution.

Supporting Patients Over Profits:

"Cannanda's commitment to 'patients over profits' is not just a motto; it's a guiding principle," says Dr. Lee Know, founder and managing director at Cannanda. "This Free Trial program underscores our dedication to improving the quality of life for those grappling with ME/CFS, long covid, and fibromyalgia. We believe everyone deserves a chance at wellness."

How to Participate:

Interested individuals can apply for the Free Trial program on Cannanda's website by clicking: www.cannanda.com/pages/free-trial-program-for-me-cfs-lc-fm